showed that METTL3-mediated m6A modification was elevated significantly in TMZ-resistant GBM cells, and METTL3 functions as a key promoter of TMZ resistance in GBM, its overexpression impaired the sensitivity of GBM cells to TMZ (144). The gene discussed is METTL3; the disease is glioblastoma.